These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 411364)
1. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure. Massie B; Chatterjee K; Werner J; Greenberg B; Hart R; Parmley WW Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364 [TBL] [Abstract][Full Text] [Related]
2. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction. Nelson GI; Silke B; Forsyth DR; Verma SP; Hussain M; Taylor SH Am J Cardiol; 1983 Nov; 52(8):1036-40. PubMed ID: 6637819 [TBL] [Abstract][Full Text] [Related]
3. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside. Pierpont GL; Cohn JN; Franciosa JA Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563 [No Abstract] [Full Text] [Related]
4. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088 [TBL] [Abstract][Full Text] [Related]
5. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise. Chatterjee K; Massie B; Rubin S; Gelberg H; Brundage BH; Ports TA Am J Med; 1978 Jul; 65(1):134-45. PubMed ID: 99031 [TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure. Gray R; Chatterjee K; Vyden JK; Ganz W; Forrester JS; Swan HJ Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426 [TBL] [Abstract][Full Text] [Related]
7. Role of nitrates in congestive heart failure. Cohn JN Am J Cardiol; 1987 Nov; 60(15):39H-43H. PubMed ID: 3120564 [TBL] [Abstract][Full Text] [Related]
8. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Steimle AE; Stevenson LW; Chelimsky-Fallick C; Fonarow GC; Hamilton MA; Moriguchi JD; Kartashov A; Tillisch JH Circulation; 1997 Aug; 96(4):1165-72. PubMed ID: 9286945 [TBL] [Abstract][Full Text] [Related]
9. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure. Mason DT Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030 [TBL] [Abstract][Full Text] [Related]
10. Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure. Massie BM; Kramer B; Shen E; Haughom F Br Heart J; 1981 Apr; 45(4):376-84. PubMed ID: 7225252 [TBL] [Abstract][Full Text] [Related]
11. Combination vasodilator therapy for severe chronic congestive heart failure. Chatterjee K; Drew D; Parmley WW; Klausner SC; Polansky J; Zacherle B Ann Intern Med; 1976 Oct; 85(4):467-70. PubMed ID: 823852 [TBL] [Abstract][Full Text] [Related]
12. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate. Williams DO; Bommer WJ; Miller RR; Amsterdam EA; Mason DT Am J Cardiol; 1977 Jan; 39(1):84-90. PubMed ID: 318795 [TBL] [Abstract][Full Text] [Related]
13. Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure. Packer M; Medina N; Yushak M; Lee WH Am J Cardiol; 1986 Feb; 57(4):260-7. PubMed ID: 3080861 [TBL] [Abstract][Full Text] [Related]
14. Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs. Packer M; Medina N; Yushak M Am Heart J; 1982 Nov; 104(5 Pt 2):1215-23. PubMed ID: 6753552 [TBL] [Abstract][Full Text] [Related]
15. [Vasodilator therapy in cardiac failure]. Akatsuka N Nihon Rinsho; 1993 May; 51(5):1276-80. PubMed ID: 8101237 [TBL] [Abstract][Full Text] [Related]
16. Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination. Leier CB; Magorien RD; Desch CE; Thompson MJ; Unverferth DV Circulation; 1981 Jan; 63(1):102-9. PubMed ID: 7438384 [TBL] [Abstract][Full Text] [Related]
17. Regression of myocardial cellular hypertrophy with vasodilator therapy in chronic congestive heart failure associated with idiopathic dilated cardiomyopathy. Unverferth DV; Mehegan JP; Magorien RD; Unverferth BJ; Leier CV Am J Cardiol; 1983 May; 51(8):1392-8. PubMed ID: 6682617 [TBL] [Abstract][Full Text] [Related]
18. Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction. Kodama K; Koretsune Y; Nanto S; Taniura K Jpn Circ J; 1984 Apr; 48(4):380-7. PubMed ID: 6425527 [TBL] [Abstract][Full Text] [Related]
19. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315 [TBL] [Abstract][Full Text] [Related]
20. Hemodynamic trial of sequential treatment with diuretic, vasodilator, and positive inotropic drugs in left ventricular failure following acute myocardial infarction. Nelson GI; Silke B; Ahuja RC; Walker C; Forsyth DR; Verma SP; Taylor SH Am Heart J; 1984 Jun; 107(6):1202-9. PubMed ID: 6144266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]